Zimmer Biomet Holdings, Inc.
Clinical trials sponsored by Zimmer Biomet Holdings, Inc., explained in plain language.
Medical device company specializing in orthopedic implants and joint replacement.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone cement tested for hip and knee implants Results expected Oct 2026 (estimated)
- New implant aims to strengthen shoulder tendon repair after replacement Results expected Nov 2026 (estimated)
- Researchers track shoulder implant longevity to improve future surgeries Results expected Dec 2026 (estimated)
- New shoulder implant study aims to ease severe arthritis and rotator cuff damage Results expected Dec 2026 (estimated)
- New study confirms shoulder fracture hardware holds up Results expected Dec 2026 (estimated)
-
Can a new hip implant stand the test of time?
Disease control Stopped earlyThis study follows about 300 people who receive a hip replacement using the GTS cementless stem, a type of implant that anchors to bone without cement. The goal is to see how well the implant performs over up to 10 years, measuring pain, function, and joint stability. Participant…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Shoulder implant under review: will it last 10 years?
Disease control Stopped earlyThis study looked at a shoulder implant used to treat pain and joint problems from conditions like arthritis, fractures, and rotator cuff tears. It involved 67 adults who received the implant and tracked how long it lasted and any side effects over 10 years. The goal was to confi…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Knee injection study halted early – limited data on pain relief
Disease control Stopped earlyThis study looked at how well a procedure called Subchondroplasty (SCP) works for people with bone marrow edema in the knee. The procedure involves injecting a synthetic bone filler into the bone to relieve pain and improve function. The study planned to follow 516 patients but w…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC